206 related articles for article (PubMed ID: 25713139)
1. COPS5 protein overexpression increases amyloid plaque burden, decreases spinophilin-immunoreactive puncta, and exacerbates learning and memory deficits in the mouse brain.
Wang R; Wang H; Carrera I; Xu S; Lakshmana MK
J Biol Chem; 2015 Apr; 290(14):9299-309. PubMed ID: 25713139
[TBL] [Abstract][Full Text] [Related]
2. COPS5 (Jab1) protein increases β site processing of amyloid precursor protein and amyloid β peptide generation by stabilizing RanBP9 protein levels.
Wang H; Dey D; Carrera I; Minond D; Bianchi E; Xu S; Lakshmana MK
J Biol Chem; 2013 Sep; 288(37):26668-77. PubMed ID: 23926111
[TBL] [Abstract][Full Text] [Related]
3. RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease.
Wang R; Palavicini JP; Wang H; Maiti P; Bianchi E; Xu S; Lloyd BN; Dawson-Scully K; Kang DE; Lakshmana MK
Neurobiol Dis; 2014 Sep; 69():169-79. PubMed ID: 24892886
[TBL] [Abstract][Full Text] [Related]
4. RanBP9 overexpression down-regulates phospho-cofilin, causes early synaptic deficits and impaired learning, and accelerates accumulation of amyloid plaques in the mouse brain.
Palavicini JP; Wang H; Minond D; Bianchi E; Xu S; Lakshmana MK
J Alzheimers Dis; 2014; 39(4):727-40. PubMed ID: 24254706
[TBL] [Abstract][Full Text] [Related]
5. RanBP9 aggravates synaptic damage in the mouse brain and is inversely correlated to spinophilin levels in Alzheimer's brain synaptosomes.
Palavicini JP; Wang H; Bianchi E; Xu S; Rao JS; Kang DE; Lakshmana MK
Cell Death Dis; 2013 Jun; 4(6):e667. PubMed ID: 23764848
[TBL] [Abstract][Full Text] [Related]
6. RanBP9 overexpression accelerates loss of pre and postsynaptic proteins in the APΔE9 transgenic mouse brain.
Wang H; Wang R; Xu S; Lakshmana MK
PLoS One; 2014; 9(1):e85484. PubMed ID: 24454876
[TBL] [Abstract][Full Text] [Related]
7. RanBP9 overexpression reduces dendritic arbor and spine density.
Wang H; Lewsadder M; Dorn E; Xu S; Lakshmana MK
Neuroscience; 2014 Apr; 265():253-62. PubMed ID: 24486966
[TBL] [Abstract][Full Text] [Related]
8. Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain.
Lakshmana MK; Hayes CD; Bennett SP; Bianchi E; Reddy KM; Koo EH; Kang DE
FASEB J; 2012 May; 26(5):2072-83. PubMed ID: 22294787
[TBL] [Abstract][Full Text] [Related]
9. Four-month treadmill exercise prevents the decline in spatial learning and memory abilities and the loss of spinophilin-immunoreactive puncta in the hippocampus of APP/PS1 transgenic mice.
Zhang L; Tang W; Chao FL; Zhou CN; Jiang L; Zhang Y; Liang X; Tang J; Qi YQ; Yang H; He Q; Zhang SS; Zhu L; Peng Y; Tang Y
Neurobiol Dis; 2020 Mar; 136():104723. PubMed ID: 31887353
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer's Disease.
Martínez-Iglesias O; Naidoo V; Carrera I; Cacabelos R
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269588
[TBL] [Abstract][Full Text] [Related]
11. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
12. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
13. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
14. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
16. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
17. Running exercise protects spinophilin-immunoreactive puncta and neurons in the medial prefrontal cortex of APP/PS1 transgenic mice.
Zhu L; Fan JH; Chao FL; Zhou CN; Jiang L; Zhang Y; Luo YM; Zhang L; Xiao Q; Yang H; Zhang SS; Wu H; Tang Y
J Comp Neurol; 2022 Apr; 530(6):858-870. PubMed ID: 34585379
[TBL] [Abstract][Full Text] [Related]
18. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
19. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
20. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice.
Leroy K; Ando K; Laporte V; Dedecker R; Suain V; Authelet M; Héraud C; Pierrot N; Yilmaz Z; Octave JN; Brion JP
Am J Pathol; 2012 Dec; 181(6):1928-40. PubMed ID: 23026200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
